Сorvalol-Darnitsa®

Sedative and antispasmodic

learn more

Сorvalol-Darnitsa®

Sedative and antispasmodic

Сorvalol-Darnitsa® is a sedative and antispasmodic. Its effect is determined by its components. The medication is indicated for neuroses with increased irritability, insomnia, as a part of comprehensive treatment of primary hypertension and vegetative-vascular dystonia, for mild spasms of coronary vessels, tachycardia, spasms of the intestine (as an antispasmodic). Soporifics and sedatives. Barbiturates in combination with other components.

More in instructions (Ukrainian version)
Form of release
Drops Solution
Appointment
Cardiovascular diseases
АТС class
АТХ N05C В02

Other forms of release

  • Сorvalol-Darnitsa® 40 mg,

    Сorvalol-Darnitsa®

Сorvalol-Darnitsa®

learn more

See also

  • METAMAX

    250 mg 40 x 250 mg caps
    METAMAX

    Cardiovascular drug

  • SPIRONOLACTONE-DARNITSA

    25 mg 30 x 25 mg tabs
    SPIRONOLACTONE-DARNITSA

    Potassium-sparing diuretic. Aldosterone antagonist

  • TONORMA®-DARNITSA

    10 film-coated tabs
    TONORMA®-DARNITSA

    Combined antihypertensive drug containing atenolol, nifedipine and chlorthalidone

  • CAPTOPRES-DARNITSA

    20 tabs
    CAPTOPRES-DARNITSA

    Combined ACE inhibitor with diuretics

  • ADRENALIN-DARNITSA

    1.8 mg/ml 10 x 1 ml
    ADRENALIN-DARNITSA

    Non-glycoside cardiotonic drug. Drug for emergency treatment

Specialized publications intended for medical institutions and doctors Limitations in obtaining information